Brief: Nabriva Therapeutics Reports Second Quarter 2020 Financial Results
06/08/2020 21:26
Aug 6 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATES
* Q2 REVENUE $500,000 VERSUS REFINITIV IBES ESTIMATE OF
$400,000
* QTRLY LOSS PER SHARE 30 CENTS
Source text for Eikon: ID:nGNX4CqjT6
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update